GB0207246D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0207246D0
GB0207246D0 GBGB0207246.0A GB0207246A GB0207246D0 GB 0207246 D0 GB0207246 D0 GB 0207246D0 GB 0207246 A GB0207246 A GB 0207246A GB 0207246 D0 GB0207246 D0 GB 0207246D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0207246.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0207246.0A priority Critical patent/GB0207246D0/en
Publication of GB0207246D0 publication Critical patent/GB0207246D0/en
Priority to AU2003226725A priority patent/AU2003226725A1/en
Priority to PCT/EP2003/003196 priority patent/WO2003080617A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GBGB0207246.0A 2002-03-27 2002-03-27 Novel compounds Ceased GB0207246D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0207246.0A GB0207246D0 (en) 2002-03-27 2002-03-27 Novel compounds
AU2003226725A AU2003226725A1 (en) 2002-03-27 2003-03-25 Pyrazolopyrimidine derivatives
PCT/EP2003/003196 WO2003080617A1 (en) 2002-03-27 2003-03-25 Pyrazolopyrimidine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0207246.0A GB0207246D0 (en) 2002-03-27 2002-03-27 Novel compounds

Publications (1)

Publication Number Publication Date
GB0207246D0 true GB0207246D0 (en) 2002-05-08

Family

ID=9933830

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0207246.0A Ceased GB0207246D0 (en) 2002-03-27 2002-03-27 Novel compounds

Country Status (3)

Country Link
AU (1) AU2003226725A1 (en)
GB (1) GB0207246D0 (en)
WO (1) WO2003080617A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
JP2009523748A (en) * 2006-01-18 2009-06-25 シエナ ビオテク ソシエタ ペル アチオニ Modulators of α7 nicotinic acetylcholine receptors and their use in therapy
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
JP2009536669A (en) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド Neurogenesis by angiotensin regulation
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593997A (en) * 1995-05-23 1997-01-14 Pfizer Inc. 4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors
AU4878601A (en) * 2000-04-20 2001-11-07 Mitsubishi Corporation Aromatic amide compounds
AU2001287898A1 (en) * 2000-09-22 2002-04-02 Stephen Garland Pyrazolopyridines and pyrazolopyridazines as antidiabetics
AU2002222293A1 (en) * 2000-12-19 2002-07-01 Smithkline Beecham P.L.C. Pyrazolo(3,4-c)pyridines as gsk-3 inhibitors
GB0100621D0 (en) * 2001-01-10 2001-02-21 Vernalis Res Ltd Chemical compounds VI

Also Published As

Publication number Publication date
WO2003080617A8 (en) 2003-11-13
AU2003226725A8 (en) 2003-10-08
AU2003226725A1 (en) 2003-10-08
WO2003080617A1 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
GB0202216D0 (en) Novel compounds
GB0205256D0 (en) Novel compounds
GB0202679D0 (en) Novel compounds
GB0206723D0 (en) Novel compounds
GB0207249D0 (en) Novel compounds
GB0207246D0 (en) Novel compounds
GB0203299D0 (en) Novel compounds
GB0200025D0 (en) Novel compounds
GB0204252D0 (en) Novel compounds
GB0202637D0 (en) Novel compounds
GB0207282D0 (en) Novel compounds
GB0200108D0 (en) Novel compounds
GB0207275D0 (en) Novel compounds
GB0202442D0 (en) Novel compounds
GB0203363D0 (en) Novel compounds
GB0203301D0 (en) Novel compounds
GB0206716D0 (en) Novel compounds
GB0206714D0 (en) Novel compounds
GB0203369D0 (en) Novel compounds
GB0203673D0 (en) Novel compounds
GB0203300D0 (en) Novel compounds
GB0206612D0 (en) Novel compounds
GB0203677D0 (en) Novel compounds
GB0206610D0 (en) Novel compounds
GB0202219D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)